RALF KRAHE to Immunohistochemistry
This is a "connection" page, showing publications RALF KRAHE has written about Immunohistochemistry.
Connection Strength
0.156
-
Mesenchyme-specific overexpression of nucleolar protein 66 in mice inhibits skeletal growth and bone formation. FASEB J. 2015 Jun; 29(6):2555-65.
Score: 0.059
-
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer. 2011 Feb 01; 117(3):606-17.
Score: 0.043
-
Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions. Am J Pathol. 2014 Aug; 184(8):2322-32.
Score: 0.014
-
Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. Neuropathol Appl Neurobiol. 2013 Jun; 39(4):390-405.
Score: 0.013
-
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology. 2005 Nov 22; 65(10):1636-8.
Score: 0.008
-
Proximal myotonic dystrophy mimicking progressive muscular atrophy. Eur J Neurol. 2005 Feb; 12(2):160-1.
Score: 0.007
-
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology. 2003 Jun 10; 60(11):1854-7.
Score: 0.006
-
Expression of human smooth muscle calponin in transgenic mice revealed with a bacterial artificial chromosome. Am J Physiol Heart Circ Physiol. 2002 May; 282(5):H1793-803.
Score: 0.006